ICICI Prudential Nifty Pharma Index Fund - IDCW
Category: Index Fund
Launch Date: 14-12-2022
AUM:
₹ 38.28 Cr
Expense Ratio
1.01%
Benchmark
NIFTY Pharma TRI
ISIN
INF109KC19L4
Minimum Investment
1000.0
Minimum Topup
1000.0
Minimum SIP Amount
500
Fund Manager
Kayzad Eghlim, Nishit Patel, Kewal Shah, Priya Sridhar
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| ICICI Prudential Nifty Pharma Index Fund - IDCW | 48.96 | - | - |
| Nifty Pharma TRI | 52.24 | 11.6 | 17.72 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
14.4091
Last change
-0.06 (-0.4157%)
Fund Size (AUM)
₹ 38.28 Cr
Performance
30.02% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index
Fund Manager
Kayzad Eghlim, Nishit Patel, Kewal Shah, Priya Sridhar
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| Sun Pharmaceutical Industries Ltd. | 24.91 |
| Dr. Reddy's Laboratories Ltd. | 11.6 |
| Cipla Ltd. | 11.28 |
| Divi's Laboratories Ltd. | 7.83 |
| Lupin Ltd. | 6.1 |
| Aurobindo Pharma Ltd. | 4.98 |
| Alkem Laboratories Ltd. | 3.73 |
| Torrent Pharmaceuticals Ltd. | 3.71 |
| Zydus Lifesciences Ltd. | 3.71 |
| Ipca Laboratories Ltd. | 2.77 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 99.95 |
| Others | 0.05 |